Medical
IO Biotech: Clinical Trials Progress: Analysts Adjust Ratings Amid New Data
Jefferies Lowers Price Target for IO Biotech Jefferies has maintained its “Buy” rating for IO Biotech (NASDAQ: IOBT) but has reduced its price target from...
Dyne Therapeutics Strengthens Leadership Team Amid Strategic Shift to Drive Growth
Dyne Therapeutics Announces Key Leadership Changes Dyne Therapeutics (Nasdaq: DYN), a clinical-stage company specializing in muscle disease therapeutics, has unveiled significant leadership appointments to bolster...
NuCana Shares Plunge 50% After Second Clinical Trial Setback in Two Years
NuCana Stock Hit Hard by Phase II Clinical Trial Failure NuCana shares plunged by half on Friday morning following the Phase II failure of a...
Coscien Biopharma Stock Plunges After Late-Stage Trial Failure
Coscien Biopharma Stock Plummets After Trial Setback The stock of Coscien Biopharma nosedived following disappointing news from its late-stage clinical trial. The company revealed that...
Firefly Neuroscience Partners with NCD, Appoints New Board Members
Firefly Neuroscience Forms Strategic Alliance with NCD Firefly Neuroscience, an AI-driven company specializing in brain health solutions, announced a strategic partnership with Neurology Consultants of...
Nuwellis Breaks DaVita Partnership, Launches Stock Offering
Nuwellis Ends Partnership with DaVita Nuwellis, Inc (NASDAQ: NUWE), a medical device company based in Eden Prairie, Minnesota, announced on Thursday the immediate termination of...
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...
Hello Alpha Partners with Evofem to Offer Phexxi
Women’s health innovator Evofem Biosciences, Inc. (OTCQB: EVFM) today announced a new market partnership with Hello Alpha , a telemedicine company with a medical team specifically trained for a...
